Why Is There A Zantac Cancer Lawsuit?
Many victims of Zantac NDMA contamination are seeking compensation from the drug companies that manufactured Zantac and its generic forms. None of the drug manufacturers issued warnings of the possible risks of taking Zantac or its generics with food, especially nitrate-containing foods, although the connection between NDMA and nitrates was known before the drug was released for sale to the general public. None of the drug manufacturers issued warnings about using Zantac for long-term use although the FDA initially approved it for short-term use only. None of the manufacturers issued warnings about the NDMA carcinogenic risk, making them liable for “failure to warn” in states that require it.
Individuals who have taken Zantac or its generics, either over-the-counter or by prescription, who have developed cancer or have been injured by regular consumption of Zantac or one of its generic forms, may be eligible to file a lawsuit or join an MDL (multi-district litigation) against the manufacturers of Zantac or its generics in order to receive monetary compensation for the illness or injury.
While there are many lawyers involved in lawsuits against the manufacturers of Zantac, there are two main claims: “defective design” of the product and “failure to warn” about the risks of taking the drug. Most of the lawsuits are by clients who have developed cancer or have died from cancer caused by Zantac or its generic forms. It is important to contact your legal authority as soon as you have been diagnosed with cancer and suspect it may be due to continued use of Zantac or its generic forms as there is a statute of limitations or time period you have before you are no longer allowed to sue for damages.
What is Zantac?
Zantac is the brand name of a drug called ranitidine. It is sold by prescription as well as over-the-counter (OTC). The brand names are Zantac, Zantac 150, Zantac Injection, or Acid Reducer. Store brands of Zantac are sold, for example, by Walmart’s “Equate” or CVS Health’s store brand.
Ranitidine belongs to the class of drugs known as H2 (or histamine-2) blockers or H2 receptor antagonists developed for long-term use to reduce stomach acid although it was originally approved for only short-term use. These drugs are sold over-the-counter to treat and relieve heartburn and gastroesophageal reflux disease (GERD). A stronger prescription form of the drug is used to treat and prevent more serious disorders such as ulcers in the stomach and intestines. Several companies manufacture and sell generic versions of both over-the-counter Zantac and the prescription versions.
What is NDMA?
In short, ranitidine (Zantac) contains NDMA (N-Nitrosodimethylamine) which is an environmental contaminant found in small amounts in water and foods such as vegetables, grilled meats, and dairy products. It has been classified as a probable carcinogen based upon animal studies.
The FDA determined that people should only consume small amounts of NDMA. Due to certain factors there are massive amounts of NDMA, far beyond what the FDA considers to be safe limits, found in individual tablets of Zantac sold over-the-counter that were tested by Valisure Pharmaceutical Company
What type of cancer does Zantac cause?
There are concerns that Zantac may be responsible for many types of cancers but anything related to the digestive system such as gastric and stomach cancers are at the top of the list. If you have been diagnosed with any cancer and have taken Zantac you should call an attorney right away.
Bladder Cancer, Brain Cancer, Breast Cancer, Colorectal Cancer/Colon and Rectal cancer, Esophageal/Throat/Nasal Cancer, Intestinal Cancer, Kidney Cancer, Leukemia, non-Hodgkin’s Lymphoma, Liver Cancer, Lung Cancer, Multiple Myeloma, Pancreatic Cancer, Prostate Cancer, Small Intestine Cancer, Stomach Cancer, Testicular Cancer
If You Developed Cancer After Taking Zantac Contact Us Today at 843-352-1440 For a Free Zantac Lawsuit Evaluation!
MDL Lawsuits vs. Class Action Lawsuits Against The Manufacturers Of Zantac Or Its Generic Forms
Due to the variety of cancers and injuries caused by NDMA Zantac contamination, each illness can be very different in its origin and outcome. Therefore, Zantac lawsuits by cancer patients or Zantac-related injuries are being combined into an MDL (multi-district litigation). MDL is a legal method for combining similar cases in order to advance litigation quickly.
While MDLs are not class action suits, they serve a similar purpose by including many people who are affected by a similar injury or illness against a large company or companies. However, when a class action suit reaches a settlement, it is divided equally among all the members in the class without regard to each individual’s unique injuries or losses. When an MDL reaches a settlement, each plaintiff gets an amount based on his/her unique claims. Each MDL plaintiff’s case is distinct and each attorney supports his/her particular client separately. Being part of an MDL allows plaintiffs to get the benefit of the strength in joining with others with similar complaints, while at the same time helping to simplify the pretrial stage and settlement process.
Joining A Lawsuit Against the Manufacturers of Zantac Or Its Generic Forms
An injured individual can join any MDL against Zantac manufactures and does not have to be a resident of the state in which the MDL is filed. But, every prospective individual seeking compensation needs a lawyer and will be subject to the Statute of Limitation Laws in the state in which they reside. To find out about your eligibility to join an MDL or other lawsuit against Zantac manufacturers, it is important to contact a lawyer as soon as cancer or injury is diagnosed.